mkc 231 has been researched along with neostigmine in 1 studies
Studies (mkc 231) | Trials (mkc 231) | Recent Studies (post-2010) (mkc 231) | Studies (neostigmine) | Trials (neostigmine) | Recent Studies (post-2010) (neostigmine) |
---|---|---|---|---|---|
11 | 0 | 3 | 5,020 | 454 | 637 |
Protein | Taxonomy | mkc 231 (IC50) | neostigmine (IC50) |
---|---|---|---|
Acetylcholinesterase | Electrophorus electricus (electric eel) | 2.54 | |
Cholinesterase | Homo sapiens (human) | 0.45 | |
Acetylcholinesterase | Homo sapiens (human) | 1.1 | |
Cholinesterase | Equus caballus (horse) | 2.93 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hotta, N; Iguchi, A; Miura, H; Surina-Baumgartner, DM; Tamagawa, T; Tamaya, N; Ueda, M; Uemura, K; Yoshioka, S | 1 |
1 other study(ies) available for mkc 231 and neostigmine
Article | Year |
---|---|
Central nervous system-mediated hyperglycemic effects of NIK-247, a cholinesterase inhibitor, and MKC-231, a choline uptake enhancer, in rats.
Topics: Aminoquinolines; Animals; Blood Glucose; Central Nervous System; Choline; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Neostigmine; Nootropic Agents; Quinolines; Rats; Rats, Wistar; Sodium Chloride | 1999 |